ArticleCancers2024

Prediction of a Multi-Gene Assay (Oncotype DX and Mammaprint) Recurrence Risk Group Using Machine Learning in Estrogen Receptor-Positive, HER2-Negative Breast Cancer-The BRAIN Study.

Jung-Hwan Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.